efalizumab - CISMeF

Preferred Label : efalizumab;

UMLS semantic type : T116 - Amino Acid, Peptide, or Protein; T121 - Pharmacologic Substance; T129 - Immunologic Factor;

Is substance : O;

Details

Origin ID

M0447098;

UMLS CUI

C1174995;

Currated CISMeF NLP mapping
- Efalizumab [NCIt concept]
- Efalizumab (substance) [SNOMED CT concept]
- efalizumab [International Nonproprietary Name]
MeSH narrower concept(s)
- HU1124 [MeSH concept]
- raptiva [MeSH concept]
Related record
- efalizumab [MeSH Supplementary Concept]
See also inter- (CISMeF)
- Product containing efalizumab (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Efalizumab [NCIt concept]
- Efalizumab (substance) [SNOMED CT concept]
- Product containing efalizumab (medicinal product) [SNOMED CT concept]
- efalizumab [ATC Code]
- efalizumab [International Nonproprietary Name]
Validated automatic mappings to BTNT
- efalizumab [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients